Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.22.2.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Equity

Note 5 – Stockholders’ Equity

Stock Options

During the six months ended June 30, 2022, no options were granted, exercised, expired, or forfeited.

For the three months ended June 30, 2022 and 2021, the Company recorded $153,093 and $226,698, respectively, of stock-based compensation expense related to stock options issued as compensation, of which $0 and $56,917, respectively, was included in net income of discontinued operations on the accompanying condensed consolidated statements of operations. During the six months ended June 30, 2022 and 2021, the Company recorded $472,044 and $509,697, respectively, of stock-based compensation expense related to stock options issued as compensation, of which $0 and $113,213, respectively, was included in net income of discontinued operations on the accompanying condensed consolidated statement of operations. As of June 30, 2022, there was $748,737 of unrecognized stock-based compensation expense related to the stock options that will be recognized over the weighted average remaining vesting period of 1.84 years.

Restricted Common Stock

A summary of the non-vested restricted common stock activity during the six months ended June 30, 2022 is presented below:

Weighted
Number of
 Average
Restricted
 Grant Date
Stock Fair Value
Non-vested balance, January 1, 2022 80,000 $ 2.00
Vested (80,000 ) 2.00
Non-vested balance, June 30, 2022
-
 $
-

For the three and six months ended June 30, 2022, the Company recorded $0 and $82,345, respectively, of stock-based compensation expense related to restricted stock. For the three and six months ended June 30, 2021, the Company recorded $80,925 and $160,931, respectively, of stock-based compensation expense related to restricted stock of which $13,712 and $27,273, respectively, was included in net income of discontinued operations on the accompanying condensed consolidated statements of operations. As of June 30, 2022, all restricted common stock was fully vested.